About AMNOL
AMNOL was established in 1978 in Novara, Italy, where operations focus on the production of dermo-cosmetics. The company specializes in this sector, developing and manufacturing skincare and cosmetic items tailored for dermatological needs. Leadership is provided by CEO Giorgio Stefanelli. Activities are centered in Italy, serving markets through its domain amnol.net, with an emphasis on quality-controlled formulations.
- Headquarter Novara, Italy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ceres Pharma Italy S.R.L
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Ceres Pharma
(May 08, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AMNOL
Detailed funding history for AMNOL
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AMNOL
AMNOL has secured backing from 1 investor. Prominent investors backing the company include Ceres Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Nutritional supplements are manufactured and marketed by Ceres Pharma.
|
Locked | Locked | Locked |
Investor details for AMNOL
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AMNOL
Investment portfolio details for AMNOL
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AMNOL
Detailed financials for AMNOL
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amnol Comparisons
Peer comparison for AMNOL
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AMNOL
Detailed competitors of AMNOL
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amnol
Complete news archive for AMNOL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AMNOL
AMNOL was founded in 1978.
AMNOL is headquartered in Novara, Italy. It is registered at Novara, Piedmont, Italy.
Giorgio Stefanelli is the current CEO of AMNOL.
AMNOL was established in 1978 in Novara, Italy, where operations focus on the production of dermo-cosmetics. The company specializes in this sector, developing and manufacturing skincare and cosmetic items tailored for dermatological needs. Leadership is provided by CEO Giorgio Stefanelli. Activities are centered in Italy, serving markets through its domain amnol.net, with an emphasis on quality-controlled formulations.
AMNOL has 1 investor. Key investors include Ceres Pharma.